Glucuronic acid derivatives of opioid antagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/202

A61K 31/70 (2006.01)

Patent

CA 1302265

ABSTRACT A composition for site-specific delivery of an opioid antagonist to the intestine of a subject without substantial systemic effects, comprising nalmefene-3.beta.-D-glucuronide or naltrexone-3.beta.-D-glucuronide in an amount sufficient to provide opioid antagonism to the intestine of the subject and a pharmaceutically acceptable carrier for oral admin- istration, preferably in the form of capsules or tablets.

556617

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glucuronic acid derivatives of opioid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucuronic acid derivatives of opioid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucuronic acid derivatives of opioid antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1176741

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.